NASDAQ : QTRX
Quanterix Corporation — Key statistics
Healthcare · Medical Devices · United States
Last price 2.905 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 137.39M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 137.39M |
| Enterprise Value | 77.24M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 47.29M |
| Shares Outstanding | 47.29M |
| Shares Change (YoY) | +21.01% |
| Shares Change (QoQ) | +0.40% |
| Owned by Insiders (%) | 7.04% |
| Owned by Institutions (%) | 59.76% |
| Float | 37.98M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.90 |
| Forward PS | 0.93 |
| PB Ratio | 0.58 |
| P/TBV Ratio | 1.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.40 |
| Quick Ratio | 2.30 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -46.48% |
| Return on Assets (ROA) | -16.67% |
| Return on Invested Capital (ROIC) | -19.36% |
| Return on Capital Employed (ROCE) | -34.43% |
| Weighted Average Cost of Capital (WACC) | 7.90% |
| Revenue Per Employee | $340,909 |
| Profits Per Employee | -$273,573 |
| Employee Count | 450 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.19 |
Taxes
| Measure | Value |
|---|
| Income Tax | -2.20M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.01 |
| 52-Week Price Change | -43.81% |
| 50-Day Moving Average | 2.99 |
| 200-Day Moving Average | 3.87 |
| Relative Strength Index (RSI) | 45.47 |
| Average Volume (20 Days) | 485,434 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.68M |
| Short Previous Month | 5.05M |
| Short % of Shares Out | 9.89% |
| Short % of Float | 12.32% |
| Short Ratio (days to cover) | 7.01 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 153.41M |
| Gross Profit | 68.36M |
| Operating Income | -92.70M |
| Pretax Income | -125.30M |
| Net Income | -123.11M |
| EBITDA | -70.50M |
| EBIT | -92.70M |
| Loss Per Share | -$2.63 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 93.53M |
| Total Debt | 33.39M |
| Net Cash | 60.14M |
| Net Cash Per Share | $1.27 |
| Equity (Book Value) | 237.21M |
| Book Value Per Share | 5.03 |
| Working Capital | 120.68M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -80.92M |
| Capital Expenditures | -762,000 |
| Depreciation & Amortization | 22.19M |
| Net Borrowing | -171,000 |
| Free Cash Flow | -81.68M |
| FCF Per Share | -$1.73 |
Margins
| Measure | Value |
|---|
| Gross Margin | 44.56% |
| Operating Margin | -60.43% |
| Pretax Margin | -81.68% |
| Profit Margin | -80.25% |
| EBITDA Margin | -45.96% |
| EBIT Margin | -60.43% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -21.01% |
| Shareholder Yield | -21.01% |
| Earnings Yield | -90.60% |
| FCF Yield | -59.45% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $3.17 |
| Price Target Difference | 9.02% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 9.16% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -1.12 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |